IBIO, INC. Capital Expenditures
IBIO, INC. (IBIO) reported Capital Expenditures of $578.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-28
- IBIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $19.00K, a 1800.00% increase year-over-year.
- IBIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $11.00K, a 21.43% decline year-over-year.
- IBIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $516.00K, a 51500.00% increase year-over-year.
- IBIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $32.00K.
- IBIO, INC. payments to acquire property, plant, and equipment for fiscal 2026 was $578.00K, a 3512.50% increase from fiscal 2025.
- IBIO, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $16.00K, a 92.38% decline from fiscal 2024.
- IBIO, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $210.00K, a 96.34% decline from fiscal 2023.
- IBIO, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $5.74M, a 21.72% decline from fiscal 2022.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | $30.00K derived: sum of 2 quarters · filed 2026-08-28 | $546.00K derived: sum of 3 quarters · filed 2026-08-28 | $578.00K 10-K · filed 2026-08-28 | |||
| 2026-03-31 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | $527.00K derived: sum of 2 quarters · filed 2026-05-12 | $559.00K 10-Q · filed 2026-05-12 | $560.00K derived: sum of 4 quarters · filed 2026-08-28 | |||
| 2025-12-31 | $516.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-10 | $548.00K 10-Q · filed 2026-02-10 | $549.00K derived: sum of 3 quarters · filed 2026-08-28 | $563.00K derived: sum of 4 quarters · filed 2026-08-28 | |||
| 2025-09-30 | $32.00K 10-Q/A · filed 2025-11-17 | $33.00K derived: sum of 2 quarters · filed 2026-08-28 | $47.00K derived: sum of 3 quarters · filed 2026-08-28 | $48.00K derived: sum of 4 quarters · filed 2026-08-28 | |||
| 2025-06-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | $15.00K derived: sum of 2 quarters · filed 2026-08-28 | $16.00K derived: sum of 3 quarters · filed 2026-08-28 | $16.00K 10-K · filed 2026-08-28 | |||
| 2025-03-31 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | $15.00K derived: sum of 2 quarters · filed 2026-05-12 | $15.00K 10-Q · filed 2026-05-12 | $225.00K derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | $1.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-10 | $1.00K 10-Q · filed 2026-02-10 | $211.00K derived: sum of 3 quarters · filed 2026-02-10 | $211.00K derived: sum of 4 quarters · filed 2026-02-10 | |||
| 2024-09-30 | $0.00 10-Q/A · filed 2025-11-17 | $210.00K derived: sum of 2 quarters · filed 2025-11-17 | $210.00K derived: sum of 3 quarters · filed 2025-11-17 | ||||
| 2024-06-30 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-05 | $210.00K derived: sum of 2 quarters · filed 2025-09-05 | $210.00K 10-K · filed 2025-09-05 | ||||
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-02 | $0.00 10-Q · filed 2025-05-02 | |||||
| 2023-12-31 | $0.00 10-Q · filed 2025-02-10 | ||||||
| 2023-06-30 | $506.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-24 | $305.00K derived: sum of 2 quarters · filed 2024-09-24 | $3.26M derived: sum of 3 quarters · filed 2024-09-24 | $5.74M 10-K/A · filed 2024-09-24 | |||
| 2023-03-31 | -$201.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-13 | $2.75M derived: sum of 2 quarters · filed 2024-05-13 | $5.23M 10-Q · filed 2024-05-13 | $8.66M derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | $5.43M 10-Q · filed 2024-02-09 | $8.86M derived: sum of 3 quarters · filed 2024-02-09 | $9.51M derived: sum of 4 quarters · filed 2024-02-09 | |||
| 2022-09-30 | $2.48M 10-Q · filed 2023-11-14 | $5.91M derived: sum of 2 quarters · filed 2023-11-14 | $6.55M derived: sum of 3 quarters · filed 2023-11-14 | $8.69M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-27 | $4.07M derived: sum of 2 quarters · filed 2023-09-27 | $6.21M derived: sum of 3 quarters · filed 2023-09-27 | $7.33M 10-K · filed 2023-09-27 | |||
| 2022-03-31 | $644.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-05-15 | $2.78M derived: sum of 2 quarters · filed 2023-05-19 | $3.90M 10-Q · filed 2023-05-15 | $6.41M derived: sum of 4 quarters · filed 2023-05-19 | |||
| 2021-12-31 | $2.13M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-05-19 | $3.26M 10-Q/A · filed 2023-05-19 | $5.77M derived: sum of 3 quarters · filed 2023-05-19 | $6.76M derived: sum of 4 quarters · filed 2023-05-19 | |||
| 2021-09-30 | $1.12M 10-Q · filed 2022-11-14 | $3.64M derived: sum of 2 quarters · filed 2022-11-14 | $4.63M derived: sum of 3 quarters · filed 2022-11-14 | $5.62M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-11 | $3.51M derived: sum of 2 quarters · filed 2022-10-11 | $4.50M derived: sum of 3 quarters · filed 2022-10-11 | $4.92M 10-K · filed 2022-10-11 | |||
| 2021-03-31 | $993.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12 | $1.99M derived: sum of 2 quarters · filed 2022-05-12 | $2.41M 10-Q · filed 2022-05-12 | $3.21M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $994.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $1.41M 10-Q · filed 2022-02-14 | $2.22M derived: sum of 3 quarters · filed 2022-02-14 | $2.29M derived: sum of 4 quarters · filed 2022-02-14 | |||
| 2020-09-30 | $419.00K 10-Q · filed 2021-11-15 | $1.23M derived: sum of 2 quarters · filed 2021-11-15 | $1.29M derived: sum of 3 quarters · filed 2021-11-15 | $1.50M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $807.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $876.00K derived: sum of 2 quarters · filed 2021-09-28 | $1.08M derived: sum of 3 quarters · filed 2021-09-28 | $1.08M 10-K · filed 2021-09-28 | |||
| 2020-03-31 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | $271.00K derived: sum of 2 quarters · filed 2021-05-17 | $271.00K 10-Q · filed 2021-05-17 | $415.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $202.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | $202.00K 10-Q · filed 2021-02-16 | $346.00K derived: sum of 3 quarters · filed 2021-02-16 | $474.00K derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-16 | $144.00K derived: sum of 2 quarters · filed 2020-11-16 | $272.00K derived: sum of 3 quarters · filed 2020-11-16 | $646.00K derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $272.00K derived: sum of 2 quarters · filed 2020-10-13 | $646.00K derived: sum of 3 quarters · filed 2020-10-13 | $920.00K 10-K · filed 2020-10-13 | |||
| 2019-03-31 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | $502.00K derived: sum of 2 quarters · filed 2020-05-15 | $776.00K 10-Q · filed 2020-05-15 | $998.00K derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $374.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $648.00K 10-Q · filed 2020-02-14 | $870.00K derived: sum of 3 quarters · filed 2020-02-14 | $1.30M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2018-09-30 | $274.00K 10-Q · filed 2019-11-14 | $496.00K derived: sum of 2 quarters · filed 2019-11-14 | $931.00K derived: sum of 3 quarters · filed 2019-11-14 | $1.11M derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26 | $657.00K derived: sum of 2 quarters · filed 2019-08-26 | $838.00K derived: sum of 3 quarters · filed 2019-08-26 | $934.00K 10-K · filed 2019-08-26 | |||
| 2018-03-31 | $435.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | $616.00K derived: sum of 2 quarters · filed 2019-05-10 | $712.00K 10-Q · filed 2019-05-10 | $1.23M derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2017-12-31 | $181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | $277.00K 10-Q · filed 2019-02-13 | $791.00K derived: sum of 3 quarters · filed 2019-02-13 | $1.06M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-09-30 | $96.00K 10-Q · filed 2018-11-13 | $610.00K derived: sum of 2 quarters · filed 2018-11-13 | $880.00K derived: sum of 3 quarters · filed 2018-11-13 | $1.02M derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-18 | $784.00K derived: sum of 2 quarters · filed 2018-09-18 | $923.00K derived: sum of 3 quarters · filed 2018-09-18 | $1.32M 10-K · filed 2018-09-18 | |||
| 2017-03-31 | $270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-11 | $409.00K derived: sum of 2 quarters · filed 2018-05-11 | $809.00K 10-Q · filed 2018-05-11 | $869.00K derived: sum of 4 quarters · filed 2018-05-11 | |||
| 2016-12-31 | $139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $539.00K 10-Q · filed 2018-02-14 | $599.00K derived: sum of 3 quarters · filed 2018-02-14 | $602.00K derived: sum of 4 quarters · filed 2018-02-14 | |||
| 2016-09-30 | $400.00K 10-Q · filed 2017-11-09 | $460.00K derived: sum of 2 quarters · filed 2017-11-09 | $463.00K derived: sum of 3 quarters · filed 2017-11-09 | $468.00K derived: sum of 4 quarters · filed 2017-11-09 | |||
| 2016-06-30 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-15 | $63.00K derived: sum of 2 quarters · filed 2017-09-15 | $68.00K derived: sum of 3 quarters · filed 2017-09-15 | $68.00K 10-K · filed 2017-09-15 | |||
| 2016-03-31 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $8.00K derived: sum of 2 quarters · filed 2017-05-15 | $8.00K 10-Q · filed 2017-05-15 | $6.00K derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-21 | $5.00K 10-Q · filed 2017-02-21 | $3.00K derived: sum of 3 quarters · filed 2017-02-21 | $3.00K derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-18 | -$2.00K derived: sum of 2 quarters · filed 2016-11-18 | -$2.00K derived: sum of 3 quarters · filed 2016-11-18 | -$1.00K derived: sum of 4 quarters · filed 2016-11-18 | |||
| 2015-06-30 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | -$2.00K derived: sum of 2 quarters · filed 2016-10-13 | -$1.00K derived: sum of 3 quarters · filed 2016-10-13 | $13.00K 10-K · filed 2016-10-13 | |||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-23 | $1.00K derived: sum of 2 quarters · filed 2016-05-23 | $15.00K 10-Q · filed 2016-05-23 | $15.00K derived: sum of 4 quarters · filed 2016-05-23 | |||
| 2014-12-31 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-22 | $15.00K 10-Q · filed 2016-02-22 | $15.00K derived: sum of 3 quarters · filed 2016-02-22 | $19.00K derived: sum of 4 quarters · filed 2016-02-22 | |||
| 2014-09-30 | $14.00K 10-Q · filed 2015-11-13 | $14.00K derived: sum of 2 quarters · filed 2015-11-13 | $18.00K derived: sum of 3 quarters · filed 2015-11-13 | $18.00K derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13 | $4.00K derived: sum of 2 quarters · filed 2015-10-13 | $4.00K derived: sum of 3 quarters · filed 2015-10-13 | $4.00K 10-K · filed 2015-10-13 | |||
| 2014-03-31 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $4.00K derived: sum of 2 quarters · filed 2015-05-15 | $4.00K 10-Q · filed 2015-05-15 | $7.00K derived: sum of 4 quarters · filed 2015-05-15 | |||
| 2013-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-24 | $0.00 10-Q · filed 2015-02-24 | $3.00K derived: sum of 3 quarters · filed 2015-02-24 | $4.00K derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-14 | $3.00K derived: sum of 2 quarters · filed 2014-11-14 | $4.00K derived: sum of 3 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $4.00K derived: sum of 2 quarters · filed 2014-09-29 | $7.00K 10-K · filed 2014-09-29 | ||||
| 2013-03-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | $4.00K 10-Q · filed 2014-05-15 | $4.44K 10-Q · filed 2013-05-20 | ||||
| 2012-12-31 | $3.00K 10-Q · filed 2014-02-14 | -$3.00K 10-Q · filed 2013-02-19 | |||||
| 2012-06-30 | $113.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-10-04 | $1.00K 10-K/A · filed 2013-10-04 | $887.00 10-K/A · filed 2012-10-15 | ||||
| 2012-03-31 | $887.00 10-Q · filed 2013-05-20 | ||||||
| 2011-06-30 | $1.22K 10-K/A · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |